HIGHLIGHTS
- who: Bao-Jin Chi and collaborators from the Department of Urology, The First Affiliated Hospital of Jiamusi University, China have published the article: Metformin Can Enhance the Inhibitory Effect of Olaparib in Bladder Cancer Cells, in the Journal: Disease Markers of 24/06/2022
- what: The results of this study showed that metformin could significantly enhance the antitumor effect of olaparib on bladder cancer cells and these effects were mediated by downregulating STAT3/C-MYC signaling pathway proteins.
- how: The CCK8 results showed that the inhibition rate of metformin and olaparib alone on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.